glp-1 agonists in development Timeline of discovery and clinical development. (a) Key events GLP1 receptor agonist @nejm revisión
Description
By inhibiting glucagon, GLP-1 helps prevent excess glucose release
Though there has been some preliminary data that GLP-1RAs might protect against cognitive decline and dementia, the research is still in clinical trials
It is influenced by appetite signaling, insulin resistance, genetics, fat distribution, hormones, sleep quality, inflammation, medications, stress, muscle mass, thyroid function, aging, and the bodys natural tendency to defend weight
Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, et al
Obesity can begin very early, with 12% of toddlers and primary school-aged children affected
